SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-21-000050
Filing Date
2021-11-15
Accepted
2021-11-15 08:36:29
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sava-20210930x10q.htm   iXBRL 10-Q 2078385
2 EX-10.4 sava-20210930xex10_4.htm EX-10.4 616311
3 EX-31.1 sava-20210930xex31_1.htm EX-31.1 25619
4 EX-31.2 sava-20210930xex31_2.htm EX-31.2 25246
5 EX-32.1 sava-20210930xex32_1.htm EX-32.1 20505
6 GRAPHIC sava-20210930x10qg001.jpg GRAPHIC 26261
7 GRAPHIC sava-20210930x10qg002.jpg GRAPHIC 48837
8 GRAPHIC sava-20210930x10qg003.jpg GRAPHIC 46460
9 GRAPHIC sava-20210930x10qg004.jpg GRAPHIC 27858
10 GRAPHIC sava-20210930x10qg005.jpg GRAPHIC 74598
  Complete submission text file 0001069530-21-000050.txt   8989094

Data Files

Seq Description Document Type Size
11 EX-101.SCH sava-20210930.xsd EX-101.SCH 33231
12 EX-101.CAL sava-20210930_cal.xml EX-101.CAL 45644
13 EX-101.DEF sava-20210930_def.xml EX-101.DEF 114163
14 EX-101.LAB sava-20210930_lab.xml EX-101.LAB 257719
15 EX-101.PRE sava-20210930_pre.xml EX-101.PRE 246688
16 EXTRACTED XBRL INSTANCE DOCUMENT sava-20210930x10q_htm.xml XML 1817317
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 211406609
SIC: 2834 Pharmaceutical Preparations